Compare ARK Genomic Revolution ETF (ARKG) vs Invesco DB Commodity Index Tracking Fund (DBC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Invesco DB Commodity Index Tracking Fund — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Invesco DB Commodity Index Tracking Fund trades at $27.24. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Invesco DB Commodity Index Tracking Fund nearer its low. Which is the better fit depends on your goals.
| ARKG | DBC | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $31.69 |
52-Week Low | $23.09 | $21.62 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
DBC trades at $27.52, down slightly by 0.22% today, with technical indicators showing a bullish trend supported by moving averages. The commodity ETF recently hit a 52-week high in April 2026, driven by oil supply shocks and safe-haven demand. Recent news highlights commodities as effective inflation hedges, with DBC gaining over 32% in the past year.
The outlook remains positive given strong momentum and institutional interest in commodities for portfolio diversification. Key risks include geopolitical tensions affecting oil supplies and potential market volatility from inflation dynamics. Analyst sentiment is constructive, with DBC positioned to benefit from ongoing commodity strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Invesco DB Commodity Index Tracking Fund
DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.
Read more on DBC →
